The World Health Organization (WHO) has announced that 102 potential Covid-19 vaccines are being developed around the world as scientists worldwide find a permanent solution to the novel Coronavirus.
This was made know when Australian research and clinical facility disclosed they preparing to lunch human trial of COVID-19 vaccine developed by China.
Four are from China, one is from England, one is American and another is a combined American and European group. No African request has been approved.
Under WHO’s coordination,China’s vaccine clinical trial request was accepted today as the WHO only had seven vaccine requests four days ago.
According to the WHO, on March 16, the American National Institute of Health (NIH) became the first institute to start testing in human trial subjects with the aim to prevent the transmission of the COVID-19 virus and protect the health of individuals.
According to documents posted on the organization’s website on Thursday, eight of the potential vaccines have been approved for clinical trial
